Abstract:Background Pathophysiological changes of Huntington's disease (HD) can precede symptom onset by decades. Robust imaging biomarkers are needed to monitor HD progression, especially before the clinical onset. Purpose To investigate iron dysregulation and microstructure alterations in subcortical regions as HD imaging biomarkers, and to associate such alterations with motor and cognitive impairments. Study Type Prospective. Population Fourteen individuals with premanifest HD (38.0 ± 11.0 years, 9 females; far‐from‐onset N = 6, near‐onset N = 8), 21 manifest HD patients (49.1 ± 12.1 years, 11 females), and 33 age‐matched healthy controls (43.9 ± 12.2 years, 17 females). Field Strength/Sequence 7 T, T1‐weighted imaging, quantitative susceptibility mapping, and diffusion tensor imaging. Assessment Volume, susceptibility, fractional anisotropy (FA), and mean diffusivity (MD) within subcortical brain structures were compared across groups, used to establish HD classification models, and correlated to clinical measures and cognitive assessments. Statistical Tests Generalized linear model, multivariate logistic regression, receiver operating characteristics with the area under the curve (AUC), and likelihood ratio test comparing a volumetric model to one that also includes susceptibility and diffusion metrics, Wilcoxon paired signed‐rank test, and Pearson's correlation. A P‐value <0.05 after Benjamini–Hochberg correction was considered statistically significant. Results Significantly higher striatal susceptibility and FA were found in premanifest and manifest HD preceding atrophy, even in far‐from‐onset premanifest HD compared to controls (putamen susceptibility: 0.027 ± 0.022 vs. 0.018 ± 0.013 ppm; FA: 0.358 ± 0.048 vs. 0.313 ± 0.039). The model with additional susceptibility, FA, and MD features showed higher AUC compared to volume features alone when differentiating premanifest HD from HC (0.83 vs. 0.66), and manifest from premanifest HD (0.94 vs. 0.83). Higher striatal susceptibility significantly correlated with cognitive deterioration in HD (executive function: r = −0.600; socioemotional function: r = −0.486). Data Conclusion 7 T MRI revealed iron dysregulation and microstructure alterations with HD progression, which could precede volume loss, provide added value to HD differentiation, and might be associated with cognitive changes. Evidence Level 2 Technical Efficacy Stage 2

Resting-state functional MRI reveals altered brain connectivity and its correlation with motor dysfunction in a mouse model of Huntington’s disease

Resting-state Fmri Reveals Potential Neural Correlates of Impaired Cognition in Huntington's Disease.

Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington’s Disease

Aberrant Resting-State Brain Activity in Huntington's Disease: A Voxel-Based Meta-Analysis

Early alterations of motor learning and corticostriatal network activity in a Huntington's disease mouse model

Evolution of aberrant brain‐wide spatiotemporal dynamics of resting‐state networks in a Huntington's disease mouse model

Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review

Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI

The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease

Linking White Matter and Deep Gray Matter Alterations in Premanifest Huntington Disease.

Aberrant functional connectivity network in subjective memory complaint individuals relates to pathological biomarkers

Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington's disease

Progressive Cognitive Deficit, Motor Impairment and Striatal Pathology in a Transgenic Huntington Disease Monkey Model from Infancy to Adulthood

Mapping the Order and Pattern of Brain Structural MRI Changes Using Change‐point Analysis in Premanifest Huntington's Disease

Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.

Differential contribution of direct and indirect pathways from dorsolateral and dorsomedial striatum to motor symptoms in Huntington's disease mice

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review

Longitudinal study of neurochemical, volumetric and behavioral changes in Q140 & BACHD mouse models of Huntington’s disease

Aging-dependent loss of functional connectivity in a mouse model of Alzheimer's disease and reversal by mGluR5 modulator

Aging-Dependent Loss of Connectivity in Alzheimer’s Model Mice with Rescue by mGluR5 Modulator

Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models